Catamaran Corp (CTRX) has doubled the size of its company with last year’s acquisition of Catalyst Health Solutions, and has put out a guidance that shows revenues of $14.6 billion run rate with a suggested EBITDA of up to $670 million for the full year, says Mark Thierer, Chairman and CEO of Catamaran Corp.
“We’ve been growing the business very aggressively, both organically and through acquisition. Now in this last year we doubled the size of the company with the acquisition of Catalyst, and came together to form Catamaran. We believed it was the perfect time to reposition the company, rebrand the company and emerge as a truly scaled alternative to the more traditional models in the pharmacy benefit management industry. So today, we are a $14 billion pharmacy benefit manager with a strong market presence in each of the important market segments in the pharmacy benefit management industry,” Thierer said.
FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.
CTRX exceeded expectations on the earnings line in the first quarter and has since put out a full-year guidance, expecting the balance of 2013 to be strong for the company, Thierer says.
“We’ve put guidance out that suggests we will have revenues in the $14.2 billion to $14.6 billion run rate. We’ve suggested that EBITDA in the $660 million to $670 million range for the full year and reiterated that guidance on our last call. We are feeling good about the outlook for the rest of the year,” Thierer said.
Catamaran Corp (USA) (CTRX) Plans to Continue Aggressive M&A Strategy
November 17, 2014
The Chairman and CEO of Catamaran Corp (CTRX) and How He Built His Business
March 30, 2015
Catamaran (CTRX), Cerner (CERN) and athenahealth (ATHN) Enable HITECH Act Meaningful Use Adoption of EHR
October 24, 2012
Recommended Reading – Google’s CFO Search: Why’d it take so long?
June 27, 2008
Recommended Reading – Why ‘say on pay’ won’t work, Fortune
November 16, 2009
